CompaniesJuniper Pharmaceuticals

Juniper Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

1,453

By Phase

PHASE2: 2NA: 2PHASE3: 2

By Status

COMPLETED: 5WITHDRAWN: 1
Funding History (20)
8-K
Aug 14, 2018
8-K
Aug 9, 2018
8-K
Jul 3, 2018
8-K
May 10, 2018
8-K
Apr 25, 2018
8-K
Mar 21, 2018
8-K
Mar 8, 2018
8-K
Feb 5, 2018
8-K
Jan 8, 2018
8-K
Nov 7, 2017
Related Companies
Catalent
acquired